Vol 13, No 1 (February 29, 2024): Chinese Clinical Oncology

Emerging insights on management of high-grade glioma

Clinicopathological, metastatic and prognostic features of stage IV esophageal adenocarcinoma versus squamous cell carcinoma: a SEER database analysis

Clinical features and mutation analysis of class 1/2/3 BRAF mutation colorectal cancer

Bioinformatics identification of characteristic genes of cervical cancer via an artificial neural network

Chinese physician perception on the treatment of chemotherapy-induced anemia: online cross-section survey study

Robotic-assisted endoluminal gastric leiomyoma resection: a novel surgical technique for benign gastroesophageal junction tumors

How to use anti-PD-1 therapy in gastric cancer: the approach in the United States

Perioperative or neoadjuvant chemotherapy for locally advanced gastric or gastroesophageal junction cancer: from independent evidence in the West, the East, and Japan to global collaboration

Prehabilitation programs in liver resection: a narrative review

The effects of radiation therapy on the heart: implications for management

Personalized radiation therapy for glioblastoma

The emerging perioperative treatment paradigm for non-small cell lung cancer: a narrative review

Adjuvant therapy for mucosal melanoma in the era of immune checkpoint inhibitors

Disease volume and risk subgroup analyses for darolutamide plus androgen-deprivation therapy and docetaxel in the phase III ARASENS: should triplet therapy become standard of care in certain metastatic hormone-sensitive prostate cancer patients?

Can we truly define ‘Fitness’ for CAR-T therapy in large B cell lymphoma patients?

Adjuvant hepatic arterial infusion chemotherapy in patients with resected hepatocellular carcinoma with microvascular invasion

Encouraging prospects with sugemalimab in relapsed or refractory extranodal natural killer/T-cell lymphoma